Calumet Statistics
Total Valuation
Calumet has a market cap or net worth of $1.51 billion. The enterprise value is $3.97 billion.
Important Dates
The next estimated earnings date is Friday, November 7, 2025, before market open.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Calumet has 86.75 million shares outstanding. The number of shares has increased by 7.37% in one year.
| Current Share Class | 86.75M |
| Shares Outstanding | 86.75M |
| Shares Change (YoY) | +7.37% |
| Shares Change (QoQ) | +0.43% |
| Owned by Insiders (%) | 4.09% |
| Owned by Institutions (%) | 39.67% |
| Float | 58.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.37 |
| Forward PS | 0.35 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.97 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.76
| Current Ratio | 0.76 |
| Quick Ratio | 0.35 |
| Debt / Equity | n/a |
| Debt / EBITDA | 36.17 |
| Debt / FCF | n/a |
| Interest Coverage | -0.75 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -3.99% |
| Return on Invested Capital (ROIC) | -6.01% |
| Return on Capital Employed (ROCE) | -10.87% |
| Revenue Per Employee | $2.51M |
| Profits Per Employee | -$279,506 |
| Employee Count | 1,620 |
| Asset Turnover | 1.49 |
| Inventory Turnover | 10.58 |
Taxes
In the past 12 months, Calumet has paid $700,000 in taxes.
| Income Tax | 700,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.70% in the last 52 weeks. The beta is 0.97, so Calumet's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | +15.70% |
| 50-Day Moving Average | 15.97 |
| 200-Day Moving Average | 15.61 |
| Relative Strength Index (RSI) | 61.63 |
| Average Volume (20 Days) | 827,339 |
Short Selling Information
The latest short interest is 10.04 million, so 11.57% of the outstanding shares have been sold short.
| Short Interest | 10.04M |
| Short Previous Month | 10.40M |
| Short % of Shares Out | 11.57% |
| Short % of Float | 17.24% |
| Short Ratio (days to cover) | 11.06 |
Income Statement
In the last 12 months, Calumet had revenue of $4.07 billion and -$452.80 million in losses. Loss per share was -$5.25.
| Revenue | 4.07B |
| Gross Profit | 21.80M |
| Operating Income | -174.00M |
| Pretax Income | -41.40M |
| Net Income | -452.80M |
| EBITDA | -24.20M |
| EBIT | -174.00M |
| Loss Per Share | -$5.25 |
Full Income StatementBalance Sheet
The company has $110.60 million in cash and $2.57 billion in debt, giving a net cash position of -$2.46 billion or -$28.33 per share.
| Cash & Cash Equivalents | 110.60M |
| Total Debt | 2.57B |
| Net Cash | -2.46B |
| Net Cash Per Share | -$28.33 |
| Equity (Book Value) | -764.10M |
| Book Value Per Share | -11.65 |
| Working Capital | -280.20M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$126.90 million and capital expenditures -$72.90 million, giving a free cash flow of -$199.80 million.
| Operating Cash Flow | -126.90M |
| Capital Expenditures | -72.90M |
| Free Cash Flow | -199.80M |
| FCF Per Share | -$2.30 |
Full Cash Flow StatementMargins
Gross margin is 0.54%, with operating and profit margins of -4.27% and -11.12%.
| Gross Margin | 0.54% |
| Operating Margin | -4.27% |
| Pretax Margin | -11.07% |
| Profit Margin | -11.12% |
| EBITDA Margin | -0.59% |
| EBIT Margin | -4.27% |
| FCF Margin | n/a |
Dividends & Yields
Calumet does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.37% |
| Shareholder Yield | -7.37% |
| Earnings Yield | -30.01% |
| FCF Yield | -13.24% |
Dividend DetailsAnalyst Forecast
The average price target for Calumet is $20.38, which is 17.19% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $20.38 |
| Price Target Difference | 17.19% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Calumet has an Altman Z-Score of 0.44 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.44 |
| Piotroski F-Score | 2 |
